Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Bacteria on Skin Boost Immune Cell Function

Published: Friday, August 17, 2012
Last Updated: Friday, August 17, 2012
Bookmark and Share
The findings provides new insights into skin health.

The harmless bacteria that thrive on the skin can help immune cells fight disease-causing microbes, according to a new study in mice.

Skin is a barrier that's one of the first lines of defense against harmful microbes. Specialized immune cells within skin tissue also help to fight invading organisms.

The skin's surface is home to surprisingly diverse communities of bacteria, collectively known as the skin microbiota.

Past research suggested that these bacteria might play a role in skin health and immune responses, but the details have been unclear.

In the new study, scientists took a closer look at how skin microbiota might influence immune cell function.

The team was led by Dr. Yasmine Belkaid of NIH's National Institute of Allergy and Infectious Diseases (NIAID), with colleagues at NIH's National Human Genome Research Institute (NHGRI) and National Cancer Institute (NCI). Their report appeared in the early online edition of Science on July 26, 2012.

The scientists worked with special germ-free mice, born and raised with no naturally occurring microbes on the skin or in the gut. These mice, the researchers found, had weakened skin immune function compared to normal mice, which have vibrant bacterial communities on their skin.

The skin tissue of normal mice contained a variety of immune cells known as T cells and diverse immune signaling molecules.

Germ-free mice, in contrast, had significantly lower levels of certain signaling molecules and unusually high levels of a type of T cell that suppresses immune function.

In separate experiments, the researchers found that the presence or absence of microbes in the gut seemed to have no effect on the skin's immune responses. This finding suggests that bacteria have unique roles at different sites in the body.

The investigators next colonized the germ-free mice with Staphylococcus epidermidis, one of the most common bacteria on human skin.

Adding this one species of bacteria triggered an immune response in the skin and led to production of cell-signaling molecules that help to combat harmful microbes.

The researchers then infected germ-free mice with the skin parasite Leishmania major. At the same time, some mice were also exposed to S. epidermidis, which colonized their skin. These colonized mice mounted an effective immune response to the parasite; the bacteria-free mice did not.

“We often have a sense that the bacteria that live on our skin are harmful,” says study co-author Dr. Julie Segre of NHGRI. “But in this study we show that these bacteria can play an important role in promoting health by preventing skin infections from becoming more prolonged, pronounced and more serious.”

“Certain inflammatory disorders of the skin have been linked to a change in the nature of the bacteria that we have on the skin, but the relationship between this change and disease was not clear,” Belkaid says.

Belkaid continued, “Our findings provide a mechanistic link showing how these bacteria can manipulate immune responses and inflammation. What remains to be done-and what we are doing in collaboration with clinicians at NIH-is to see how relevant our findings in mice might be when applied to humans.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
Friday, July 29, 2016
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Wednesday, July 27, 2016
NIH Investment Into HIV Research Expands
Funding has been awarded to six research teams to lead collaborative investigations worldwide toward an HIV cure.
Thursday, July 14, 2016
Drug Might Help Treat Sepsis
A DNA enzyme called Top1 plays a key role in turning on genes that cause inflammation in mouse and human cells in response to pathogens. A drug blocking this enzyme rescued mice from lethal inflammatory responses, suggesting a potential treatment for sepsis.
Wednesday, May 18, 2016
Large-scale HIV Vaccine Trial to Launch in South Africa
NIH-funded study will test safety, efficacy of vaccine regimen.
Wednesday, May 18, 2016
New HIV Vaccine Target Discovered
NIH-Led team have discovered a new vaccine target site on HIV.
Tuesday, May 17, 2016
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
Wednesday, April 27, 2016
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
Thursday, April 21, 2016
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
Wednesday, April 20, 2016
Submissions Open for the Cancer Moonshot Program
NCI opens online platform to submit ideas about research for Cancer Moonshot.
Tuesday, April 19, 2016
NIH Awards Grants to Explore Vaccine Adjuvants
NIH awards six grants to explore how combination adjuvants improve vaccines.
Wednesday, April 06, 2016
Experimental Vaccine Protects Against Dengue Virus
An experimental dengue vaccine protected all the volunteers who received it from infection with a live dengue virus.
Wednesday, March 30, 2016
Experimental Ebola Antibody Protects Monkeys
Antibody isolated from Ebola survivor can advance to clinical trials.
Friday, February 26, 2016
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Friday, January 15, 2016
In Uveitis, Bacteria in Gut May Instruct Immune Cells to Attack the Eye
NIH scientists propose novel mechanism to explain autoimmune uveitis.
Wednesday, August 19, 2015
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Gut Bacteria Older than Human Species
Some bacteria have lived in the human gut since before we were human, suggesting evolution could have a larger role inhuman bacterial makeup.
Evidence of Mosquito Transmitting Zika
A direct link between the Yellow fever mosquito and Zika transmission has been found following investigation into selective mosquito control.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Mapping Zika’s Routes to Developing Fetus
UC researchers show how Zika virus travels from a pregnant woman to her fetus, and also identified a drug that could stop it.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!